Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 24, 2018 Off

Real-world evidence shows weight loss in people receiving Saxenda

By Dino Mustafić

People treated with Saxenda for weight management lost an average of 8.1 kg after six months in a real-world clinical…

Lilly’s psoriasis treatment first FDA approved to include data in psoriasis involving the genital area
May 23, 2018 Off

Lilly’s psoriasis treatment first FDA approved to include data in psoriasis involving the genital area

By Dino Mustafić

Eli Lilly said Tuesday that the U.S. Food and Drug Administration (FDA) has approved a label update for Taltz injection 80 mg/mL to…

May 22, 2018 Off

Circassia Pharmaceuticals presents positive data from tested long-acting muscarinic antagonists

By Dino Mustafić

Circassia Pharmaceuticals showed positive clinical data from two studies of Tudorza and Duaklir, nearing the a deal with AstraZeneca in the United…

4D pharma to investigate MRx0518 in multiple cancer settings
May 21, 2018 Off

4D pharma to investigate MRx0518 in multiple cancer settings

By Dino Mustafić

The Medicines and Healthcare products Regulatory Agency (MHRA) has cleared 4D pharma’s Clinical Trial Application for MRx0518, a live biotherapeutic…

AstraZeneca gets Lokelma approval
May 21, 2018 Off

AstraZeneca gets Lokelma approval

By Dino Mustafić

The US Food and Drug Administration (FDA) has approved Lokelma (sodium zirconium cyclosilicate), formerly ZS-9, for the treatment of adults…

FDA approves Aimovig for migraine
May 18, 2018 Off

FDA approves Aimovig for migraine

By Dino Mustafić

The US Food and Drug Administration (FDA) has approved Novartis’s and Amgen’s Aimovig (erenumab) for the preventive treatment of migraine in…

May 16, 2018 Off

Sanofi, Regeneron explore Dupixent’s role in targeting Type 2 inflammation as an underlying cause of atopic dermatitis

By Dino Mustafić

Sanofi’s pivotal Phase 3 test of Dupixent (dupilumab) to treat moderate-to-severe atopic dermatitis in adolescents met its primary and key secondary…

Idorsia enrols first patient in study to test lucerastat as treatment for Fabry disease
May 16, 2018 Off

Idorsia enrols first patient in study to test lucerastat as treatment for Fabry disease

By Dino Mustafić

Idorsia has enrolled the first patient in a Phase 3 registration study to investigate the effect of lucerastat, as an…

Lilly buys ARMO for $1.6 billion
May 10, 2018 Off

Lilly buys ARMO for $1.6 billion

By Dino Mustafić

Eli Lilly will buy ARMO BioSciences for $50 per share, or approximately $1.6 billion, the companies said Thursday. 

May 8, 2018 Off

Merck, AstraZeneca get EMA’s approval for Lynparza for women with platinum-sensitive ovarian cancer

By Dino Mustafić

AstraZeneca and Merck have gotten EMA’s approval of Lynparza tablets for use twice daily, as a maintenance therapy for patients…

Posts pagination

Previous 1 … 3,390 3,391 3,392 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine